alendronate has been researched along with betadex in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lee, HT; Liu, XM; Marky, LA; Reinhardt, RA; Wang, D | 1 |
| Celebi, N; Değim, Z; Karamustafa, F; Unal, N | 1 |
| Le, HO; Marx, DB; Narayana, N; Powell, SE; Price, U; Reinhardt, RA; Schmid, MJ; Wang, D; Zhang, Y | 1 |
| Chen, S; Jing, C; Li, B; Liang, H; Liu, C; Na, H; Tan, H; Zhang, C; Zhao, L | 1 |
4 other study(ies) available for alendronate and betadex
| Article | Year |
|---|---|
Novel biomineral-binding cyclodextrins for controlled drug delivery in the oral cavity.
Topics: Alendronate; beta-Cyclodextrins; Calorimetry; Delayed-Action Preparations; Dexamethasone; Drug Delivery Systems; Durapatite; Kinetics; Magnetic Resonance Spectroscopy; Mouth; Solubility | 2007 |
Transport evaluation of alendronate across Caco-2 cell monolayers.
Topics: Absorption; Alendronate; beta-Cyclodextrins; Biological Transport, Active; Bone Density Conservation Agents; Caco-2 Cells; Cell Membrane Permeability; Cell Survival; Electric Impedance; Excipients; Humans; Taurocholic Acid; Tetrazolium Salts; Thiazoles | 2009 |
Effects of local simvastatin-alendronate conjugate in preventing periodontitis bone loss.
Topics: Alendronate; Alveolar Bone Loss; Animals; beta-Cyclodextrins; Bone Density Conservation Agents; Drug Combinations; Endotoxins; Escherichia coli; Female; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Imaging, Three-Dimensional; Injections; Lipopolysaccharides; Maxillary Diseases; Molar; Osteoclasts; Palate; Periodontitis; Premedication; Rats; Rats, Sprague-Dawley; Sequestering Agents; Simvastatin; X-Ray Microtomography | 2013 |
Alendronate-Decorated Nanoparticles as Bone-Targeted Alendronate Carriers for Potential Osteoporosis Treatment.
Topics: Alendronate; Alginates; Animals; beta-Cyclodextrins; Bone and Bones; Bone Density Conservation Agents; Cell Line; Cell Survival; Delayed-Action Preparations; Drug Carriers; Drug Liberation; Durapatite; Erythrocytes; Goats; Hemolysis; Mice; Nanoparticles; Osteoporosis; Polylactic Acid-Polyglycolic Acid Copolymer | 2021 |